Business Description
Vaxart Inc
NAICS : 325414
SIC : 2836
ISIN : US92243A2006
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.32 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.24 | |||||
Debt-to-EBITDA | -0.29 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -3.65 | |||||
Beneish M-Score | 40.74 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.5 | |||||
3-Year EBITDA Growth Rate | -17.1 | |||||
3-Year EPS without NRI Growth Rate | -15.8 | |||||
3-Year FCF Growth Rate | -20.8 | |||||
3-Year Book Growth Rate | -30.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 6.6 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 27.13 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 8.55 | |||||
9-Day RSI | 28.28 | |||||
14-Day RSI | 36.36 | |||||
6-1 Month Momentum % | -40 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.54 | |||||
Quick Ratio | 4.54 | |||||
Cash Ratio | 3.97 | |||||
Days Sales Outstanding | 23.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.6 | |||||
Shareholder Yield % | -29.46 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -479.45 | |||||
Net Margin % | -483.35 | |||||
FCF Margin % | -392.59 | |||||
ROE % | -108.05 | |||||
ROA % | -72.39 | |||||
ROIC % | -133.96 | |||||
3-Year ROIIC % | -199.53 | |||||
ROC (Joel Greenblatt) % | -198.32 | |||||
ROCE % | -80.3 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 8.29 | |||||
PB Ratio | 2.31 | |||||
Price-to-Tangible-Book | 2.54 | |||||
EV-to-EBIT | -1.93 | |||||
EV-to-EBITDA | -2.2 | |||||
EV-to-Revenue | 9.01 | |||||
EV-to-Forward-Revenue | 6.21 | |||||
EV-to-FCF | -2.26 | |||||
Price-to-Median-PS-Value | 1.94 | |||||
Price-to-Net-Current-Asset-Value | 4.78 | |||||
Price-to-Net-Cash | 6.25 | |||||
Earnings Yield (Greenblatt) % | -51.81 | |||||
FCF Yield % | -33.79 | |||||
Forward Rate of Return (Yacktman) % | -1812.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vaxart Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 274.659 | ||
EPS (TTM) (MXN) | -7.953 | ||
Beta | 0.76 | ||
Volatility % | 79.15 | ||
14-Day RSI | 36.36 | ||
14-Day ATR (MXN) | 0.002441 | ||
20-Day SMA (MXN) | 12 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (MXN) | 10 - 23 | ||
Shares Outstanding (Mil) | 227.44 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vaxart Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vaxart Inc Stock Events
Event | Date | Price(MXN) | ||
---|---|---|---|---|
No Event Data |
Vaxart Inc Frequently Asked Questions
What is Vaxart Inc(MEX:VXRT)'s stock price today?
When is next earnings date of Vaxart Inc(MEX:VXRT)?
Does Vaxart Inc(MEX:VXRT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |